How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir

Documenti analoghi

• Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
  di: Malet, Isabelle, et al.
  Pubblicazione: (2018)
• Mutations in the HIV-1 3′-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance
  di: Wei, Yuliang, et al.
  Pubblicazione: (2021)
• Variability in HIV-1 Integrase Gene and 3′-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy
  di: Acharya, Arpan, et al.
  Pubblicazione: (2020)
• In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
  di: Smith, Robert A, et al.
  Pubblicazione: (2015)
• 7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
  di: Ziegler, Robert E., et al.
  Pubblicazione: (2018)